Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
53,141,372
-
Share change
-
+2,279,313
-
Total reported value
-
$8,263,546,157
-
Put/Call ratio
-
84%
-
Price per share
-
$155.50
-
Number of holders
-
314
-
Value change
-
+$374,758,650
-
Number of buys
-
162
-
Number of sells
-
136
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2017
As of 30 Jun 2017,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
314 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,141,372 shares.
The largest 10 holders included
PUTNAM INVESTMENTS LLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, CADIAN CAPITAL MANAGEMENT, LP, Bank of New York Mellon Corp, WESTFIELD CAPITAL MANAGEMENT CO LP, RENAISSANCE TECHNOLOGIES LLC, and FIL Ltd.
This page lists
314
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.